Supply Chain Intelligence

Charles River Laboratories International, Inc. Supply Chain

CRL supply chain intelligence for Charles River Laboratories International, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

CRL ·Last updated 2026-09-13 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
12Customers
2Debt Items
15Related Chains

Source-Backed Evidence Depth

Charles River Laboratories International, Inc. (CRL) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

19Total relationships
2Distinct source URLs
11High confidence
0.786Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Charles River Laboratories International, Inc. Suppliers

TickerNameConfidenceEvidence
GLOBAL-PHARMACEUTICAL-AND-BIOTECHNOLOGY-COMPANIE GLOBAL-PHARMACEUTICAL-AND-BIOTECHNOLOGY-COMPANIE 80% Biologics Solutions is comprised of both our Biologics Testing Solutions business, which provides specialized testing of biologics frequently outsourced by global pharmaceutical and biotechnology companies
TWST Twist Bioscience Corporation 72% Reciprocal relationship from TWST graph: Reciprocal relationship from CRL graph: Reciprocal relationship from TWST graph: ies, Inc., Eurofins Genomics Blue Heron, Elegen Corporation, Ansa Biotechnolo…
GLPG Lakefront Biotherapeutics NV 62% Reciprocal relationship from GLPG graph: Reciprocal relationship from CRL graph: Reciprocal relationship from GLPG graph: 24: € 49.5 thousand) related to tax assistance. The Audit Committee and the B…
GRDX GridAI Technologies Corp. 62% Reciprocal relationship from GRDX graph: e API is derived is kept at a storage facility maintained by Charles River Laboratories Inc. Adrulipase drug substance and drug product are currently manufact…

Charles River Laboratories International, Inc. Customers

TickerNameConfidenceEvidence
CLIENTS CLIENTS 92% Cell Solutions which supplies controlled, consistent, customized primary cells and blood components derived from normal and mobilized peripheral blood and bone marrow as well as cells from disease st…
ACADEMIC-INSTITUTIONS ACADEMIC-INSTITUTIONS 90% Our client base includes major global pharmaceutical companies, many biotechnology companies; agricultural and industrial chemical, life science, veterinary medicine, medical device, diagnostic and c…
CONTRACT-RESEARCH-AND-CONTRACT-MANUFACTURING-ORG CONTRACT-RESEARCH-AND-CONTRACT-MANUFACTURING-ORG 90% Our client base includes major global pharmaceutical companies, many biotechnology companies; agricultural and industrial chemical, life science, veterinary medicine, medical device, diagnostic and c…
GLOBAL-PHARMACEUTICAL-AND-BIOTECHNOLOGY-COMPANIE GLOBAL-PHARMACEUTICAL-AND-BIOTECHNOLOGY-COMPANIE 90% Our client base includes major global pharmaceutical companies, many biotechnology companies
GOVERNMENT-AGENCIES GOVERNMENT-AGENCIES 90% Our client base includes major global pharmaceutical companies, many biotechnology companies; agricultural and industrial chemical, life science, veterinary medicine, medical device, diagnostic and c…
HOSPITALS HOSPITALS 90% Our client base includes major global pharmaceutical companies, many biotechnology companies; agricultural and industrial chemical, life science, veterinary medicine, medical device, diagnostic and c…
K-F-CAMBODIA-LTD K-F-CAMBODIA-LTD 85% safety testing services using next-generation sequencing and bioinformatics to support biopharmaceutical product development and manufacturing, resulting in a 100% controlling interest. The prelimina…
TWST Twist Bioscience Corporation 72% Reciprocal relationship from TWST graph: ies, Inc., Eurofins Genomics Blue Heron, Elegen Corporation, Ansa Biotechnologies, Inc., Telesis Bio, Inc. and others. Additionally, we compete with both larg…
CHARLES-RIVER-LABORATORIES-INTERNATIONAL-INC CHARLES-RIVER-LABORATORIES-INTERNATIONAL-INC 62% safety testing services using next-generation sequencing and bioinformatics to support biopharmaceutical product development and manufacturing, resulting in a 100% controlling interest. The prelimina…
DELAWARE-GENERAL-CORPORATION DELAWARE-GENERAL-CORPORATION 62% , or might not be fully enforceable. Our intellectual property rights might not prevent our competitors from independently developing intellectual property that is similar to or duplicative of ours. …
NOVEPRIM-GROUP NOVEPRIM-GROUP 62% ssures, we believe clients will continue to benefit from the long-term value of strategic outsourcing to improve their operating efficiency and to access capabilities that they do not maintain intern…
SAMDI-TECH-INC SAMDI-TECH-INC 62% hase the remaining 10% equity interest up until one month after the sixth anniversary of closing the 41% equity interest. On the first anniversary of the expiration of the call option, a 12-month put…

Charles River Laboratories International, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
CRL-DEBT-7212 Xbrl Convertible 90% xbrl convertible detail from xbrl 2013-03-30.
CRL-DEBT Debt stack $1.6B 90% Market cache reports total debt of $1.6B.

Charles River Laboratories International, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Charles River Laboratories International, Inc..

Charles River Laboratories International, Inc. Ownership

HolderNameConfidenceEvidence
CRL-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC VANGUARD CAPITAL MANAGEMENT LLC 90% 13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 565 tracked holders.

Charles River Laboratories International, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
GRDX GridAI Technologies Corp. 100.00 1 ['supplier']
GLPG Lakefront Biotherapeutics NV 100.00 1 ['supplier']
TWST Twist Bioscience Corporation 100.00 1 ['customer', 'supplier']
GILD Gilead Sciences, Inc. 50.00 2
IBIO iBio, Inc. 50.00 2
TKPHF Takeda Pharmaceutical Company Limited 50.00 2
AZTA Azenta, Inc. 50.00 2
TMO Thermo Fisher Scientific Inc. 50.00 2
SPRB Spruce Biosciences, Inc. 50.00 2
SNYNF Sanofi 50.00 2
XOMA XOMA Royalty Corporation 50.00 2
GRAL GRAIL, Inc. 50.00 2
XOMAP XOMA Royalty Corporation 50.00 2
A Agilent Technologies, Inc. 50.00 2
ACET Adicet Bio, Inc. 50.00 2
Browse supply chain intel →

See the full supply chain map, all relationships, and real-time alerts for Charles River Laboratories International, Inc..

Unlock full CRL data — View plans →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map
🔐
CRL
Unlock CRL Supply Chain Data
Verified relationships include:
GLOBAL-PHARMACEUTICAL-AND-BIOTECHNOLOGY-COMPANIEGLOBAL-PHARMACEUTICAL-AND…Supplier80%
TWSTTwist Bioscience CorporationSupplier72%
CLIENTSCLIENTSCustomer92%
ACADEMIC-INSTITUTIONSACADEMIC-INSTITUTIONSCustomer90%
+15 more relationships locked
Subscribe — View plans →
Already a subscriber? Sign in →